moderna vaccine - Search News

News

Moderna, flu vaccine

U.S. News & World Report · 1h

Moderna’s New Flu Shot Shows Strong Results in Older Adults

The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA. Copyright © 2025 HealthDay. All rights reserved.

Experimental Moderna flu shot more effective than approved vaccine, company says

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to the Centers for Disease Control and Prevention.

The Silicon Review · 2h

Moderna flu shot outperforms marketed vaccines in pivotal late-stage trial

Moderna’s mRNA flu shot outperforms existing vaccines in Phase 3 trial, showing over 26% greater efficacy—paving the way for FDA approval and 2026 rollout.

4d

FDA expanding COVID vaccine warnings over rare heart side effect

The U.S. Food and Drug Administration is now requiring two common COVID-19 vaccines to update their warning labels to include ...

1d

Stock Movers: Circle Falls, Disney Climbs, Moderna Meets Flu Shot Goal

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Moderna, Merck, UroGen, Score RSV and Cancer Nods in June

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results